Network Pharmacology-Serum Metabolomics Integration Identifies Key Targets, Biomarkers and Mechanism of Sendeng-4 in Rheumatoid Arthritis Therapy
Fengye Zhou, Jun Li, Yiyang Zhou, Xueying Zhang, Jun Luo, Xinkui Li, Wenlong Sun, Qian Zhang, Mengyao Li · 2026
Read Network Pharmacology-Serum Metabolomics Integration Identifies Key Targets, Biomarkers and Mechanism of Sendeng-4 in Rheumatoid Arthritis Therapy by Fengye Zhou, Jun Li, Yiyang Zhou, Xueying Zhang, Jun Luo, Xinkui Li, Wenlong Sun, Qian Zhang, Mengyao Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13092457.txt.
Description
PurposeRheumatoid arthritis (RA) is characterized by chronic inflammatory synovitis and immunometabolic dysregulation, necessitating safer multi-target therapies. Sendeng-4 (SD-4) is a traditional Mongolian medicinal formula composed of four botanical ingredients (Xanthoceras sorbifolia Bunge, Gardenia jasminoides Ellis, Chebulae Fructus, and Toosendan Fructus) traditionally used for RA. However, its circulating material basis and mechanisms remain unclear.
Catalog record
| CREATOR | Fengye Zhou, Jun Li, Yiyang Zhou, Xueying Zhang, Jun Luo, Xinkui Li, Wenlong Sun, Qian Zhang, Mengyao Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |